- Home
- EML vs SCPH Comparison
EML vs SCPH Comparison
Compare EML & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- SCPH
- Stock Information
- Founded
- EML 1858
- SCPH 2013
- Country
- EML United States
- SCPH United States
- Employees
- EML N/A
- SCPH N/A
- Industry
- EML Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- SCPH Health Care
- Exchange
- EML Nasdaq
- SCPH Nasdaq
- Market Cap
- EML 171.1M
- SCPH 163.3M
- IPO Year
- EML N/A
- SCPH 2017
- Fundamental
- Price
- EML $29.87
- SCPH $5.05
- Analyst Decision
- EML
- SCPH Strong Buy
- Analyst Count
- EML 0
- SCPH 2
- Target Price
- EML N/A
- SCPH $19.00
- AVG Volume (30 Days)
- EML 36.0K
- SCPH 378.8K
- Earning Date
- EML 08-06-2024
- SCPH 08-14-2024
- Dividend Yield
- EML 1.47%
- SCPH N/A
- EPS Growth
- EML 65.47
- SCPH N/A
- EPS
- EML 1.92
- SCPH N/A
- Revenue
- EML $273,702,675.00
- SCPH $24,048,000.00
- Revenue This Year
- EML N/A
- SCPH $195.62
- Revenue Next Year
- EML N/A
- SCPH $145.07
- P/E Ratio
- EML $15.51
- SCPH N/A
- Revenue Growth
- EML N/A
- SCPH 549.77
- 52 Week Low
- EML $16.10
- SCPH $3.24
- 52 Week High
- EML $35.78
- SCPH $7.71
- Technical
- Relative Strength Index (RSI)
- EML 54.35
- SCPH 52.33
- Support Level
- EML $29.30
- SCPH $4.86
- Resistance Level
- EML $31.35
- SCPH $5.30
- Average True Range (ATR)
- EML 1.00
- SCPH 0.30
- MACD
- EML -0.06
- SCPH -0.02
- Stochastic Oscillator
- EML 47.67
- SCPH 30.66
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.